Oral Antibiotics in Acne: Still a Place in the Evolving Treatment Landscape

An expert discusses the shift in acne treatment from broad-spectrum antibiotics to targeted and nonantibiotic therapies, emphasizing microbiome preservation, resistance reduction, and personalized patient care.

An expert discusses how updated guidelines, patient preferences, and insurance access shape responsible oral antibiotic use in acne care, highlighting the importance of stewardship, shared decision-making, and equitable treatment access.

An expert discusses how clinical presentation guides the selective use of oral antibiotics for moderate acne, emphasizing short-term treatment, careful transitions to maintenance therapy, and individualized plans to achieve lasting skin clearance while minimizing antibiotic exposure.

An expert discusses how the primary effectiveness of oral antibiotics in acne lies in their anti-inflammatory properties—especially those of tetracyclines—highlighting their broader immunomodulatory benefits and the importance of patient education to support informed, science-based treatment decisions.

An expert discusses the importance of setting clear treatment timelines and goals for oral antibiotics in acne, emphasizing a short-term, combination approach with topicals, careful antibiotic selection based on adverse effects and spectrum, and the benefits of narrow-spectrum agents to support stewardship and patient adherence.

An expert discusses the preference for narrow-spectrum oral antibiotics in acne treatment due to their favorable safety profile, emphasizing a short-term, combination approach aligned with stewardship principles and the need to balance clinical effectiveness, patient preferences, and access challenges.

An expert discusses recent innovations in acne treatment—including the first narrow-spectrum oral antibiotic, an advanced triple-combination topical, and emerging procedural options—highlighting their roles in personalized care, antibiotic stewardship, and achieving long-term therapeutic success.

An expert discusses how insurance limitations hinder access to newer, more effective acne treatments, emphasizing the need for long-term cost-benefit recognition, while also highlighting the ongoing role of oral antibiotics and the importance of personalized care—especially for adult women with distinct acne profiles.